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Structural homologies between link proteins and proteoglycan monomers are demonstrated. A possible re- 
dundancy in the proteoglycan monomers structure is discussed and the link proteins domains homologous 
to other proteins are specified. 
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1. INTRODUCTION 
In the cartilage matrix the proteoglycan 
monomers (PG) are built up of a central protein 
core along which various glycosidic side chains are 
covalently bound; they form stable aggregates by 
interaction with hyaluronic acid and link proteins 
(LP) [l]. Despite their heterogeneity, bovine nasal 
cartilage PG gave rise to cyanogen bromide 
fragments sufficiently homogeneous for primary 
structure studies [2,3]. One of them, termed CN-2, 
after reduction and alkylation gave rise to a frag- 
ment which presented an N-terminal amino acid 
sequence strikingly homologous with two LP pep- 
tides [4]; in addition, CN-2 contained mannose- 
rich structures which could be involved in N-linked 
oligosaccharides [5]. 
These two observations prompted us to focus 
our structural studies on this particular CN-2 frag- 
ment. The recently reported sequence of LP re- 
vealed a tandemly repeated structure [6]: it was of 
interest to know whether in PG such a structure 
could be demonstrated in order to increase the 
structural relationship between PG and LP. 
* To whom correspondence should be addressed 
2. MATERIALS AND METHODS 
Cyanogen bromide treatment of PG gave rise to 
three major fractions (CN-1, CN-2 and CN-3); 
after reduction and alkylation of CN-2, CN-2 
RA/6 Bl was purified by Sepharose CLdB 
chromatography [2]. Diphenylcarbamyl chloride- 
treated trypsin (EC 3.4.21.4) was from Sigma, 
Staphylococcus aureus V8 protease (EC 3.4.21.19) 
from Miles, and Sephadex G-10, G-25 and G-75 
from Pharmacia. Reverse-phase HPLC was per- 
formed on an aquapore RP-300 column 
(Brownlee) in 0.1% trifluoroacetic acid (TFA) us- 
ing a O-40% acetonitrile gradient (Gilson 
chromatdgraph). Automated Edman degradation 
was carried out in a Beckman 890 C sequencer by 
the 0.1 M quadrol single cleavage method; the 
phenylthiohydantoin-amino acids were charac- 
terized as described in [7]. Dansylation was per- 
formed according to [8]. Enzymic digestions were 
performed in a 50 mM ammonium bicarbonate, 
2 mM EDTA (PH 7.8) buffer at 37°C for 6 h at an 
enzyme/substrate ratio of 1: 50. 
3. RESULTS AND DISCUSSION 
The tryptic and V8 protease digests of the CN-2 
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RA/6 Bl fraction were desalted by Sephadex G-10 
filtration in 30010 acetic acid. Preliminary separa- 
tion of the peptides from both origins was achieved 
by Sephadex G-25 filtration in 30% acetic acid. 
The materials recovered in the excluded peaks were 
applied to Sephadex G-75 in 2 M CaC12; the 
recovered fractions were then desalted on 
Sephadex G-l 0. 
The peptides contained in the Sephadex G-25 or 
G-75 included fractions were isolated by reverse- 
phase HPLC. Several were quite pure and could be 
submitted to amino acid sequence analysis. Table 
Table 1 
Amino acid sequences of tryptic (T) and Staphylococcus aweus V8 protease (V) 
peptides from CN-2 RA16B 1 
Tl FATR 
T2 GLDK 
T3 QACLR 
T4 AAWSR 
TS YPISK 
T6 LPGGVF 
T7 HPRVGDK 
T8 YPI VSPR 
T9 TPCGVDK 
TlOYSLTFEEAK 
Tll PACGGDKPGVR 
TIZARPNCGGNLLGVR 
T13 TPCGVDKDS S PGVR 
T14TVYLHAXQTGYPDPSSR 
TISTVYLYPXQTGLLDPLS R 
T16YPI VTPRPACGGDKPGVR 
T17TGAI I ASPEQLQAAYEAGYEQCDAGWLQD 
VI AQEFCE 
V2 AGYEQCD 
V3 VFFATRLE 
V4 VYCYVDRLE 
VS TYDVYCYVDRLE 
V6 Al CYTGEDFVDI PE 
V7 TYDVYCYVDRLEGE 
VS AKQACLRTGAI I AS PE 
V9 AGYEQCDAGWLQDQT 
VlOSQAAT;; ; T GQLYAAWSRGLDKCYAGWLADG 
For peptides T17, V9 and VlO, only the N-terminal sequences are indicated 
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1 presents the sequences determined so far; the 
peptides are listed as a function of their size: some 
of them are redundant. Table 2 is an attempt at 
alignment of some tryptic and staphylococcal pep- 
tides (table 1) from CN-2 RA/6 Bl with the 
tandemly repeated sequence in LP. It is obvious 
that CN-2 RA/6 Bl presents high homology with 
this LP region and its different tryptic and S. 
aureus V8 protease peptides have an average of 
about 50% identical amino acids encountered in 
homologous positions in one or the other tandemly 
repeated LP sequence (44% identical residues be- 
tween the two compared LP sequences). In ad- 
Our results did not rule out the existence of dif- 
ferent PG populations. Nevertheless the existence 
of a structural homology between LP and PG 
might reflect the involvement of these structures in 
a particular biological function: we suggest hat 
they might be involved in their hyaluronic acid- 
binding capacity. Previously we noted that the N- 
terminal sequence of LP presents homologies with 
immunoglobulin-like proteins [9]: the present 
study extends our knowledge concerning the do- 
mains organization of LP as their C-terminal 
redundant part is homologous to proteoglycan 
monomers (scheme 1). 
1 
LF WI 
124 161 339 
I 1 
Homology with immunoglobulin Homology with proteoglycan 
like proteins [9] monomers (present data) 
Scheme 1. Structural homologies of link proteins (LP) with other proteins. 
dition a redundancy in CN-2 RA/6 Bl can be 
postulated: the latter might explain the slight 
heterogeneity observed at positions 6, 7 and 9 of 
peptide V-10. The previously determined N- 
terminal sequence of CN-2 RA/6 Bl [3] has been 
lengthened and is included in this table (N-t). 
No amino acid could be characterized at step 7 
in peptides T-14 and T-15; glucosamine was the 
only amino sugar characterized in both of them. 
These peptides were submitted to six Edman 
degradation cycles and the resulting products were 
dansylated. Dansyl-aspartic acid was then 
characterized at position 7 in peptides T-14 and 
T-15 indicating that N-glycosylation occurred at an 
identical position in both, the classical Asn-X-Thr 
code sequence being implicated. The two peptides 
are homologous: they could not be aligned with the 
LP sequence [a]. 
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